Comparison
Why is Chromadex Corp. ?
- The company has been able to generate a Return on Equity (avg) of 5.86% signifying low profitability per unit of shareholders funds
- OPERATING CASH FLOW(Y) Lowest at USD 4.36 MM
- DEBT-EQUITY RATIO (HY) Highest at -77.7 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.65 times
- Over the past year, while the stock has generated a return of -74.60%, its profits have risen by 53.1% ; the PEG ratio of the company is 0.4
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 3.96% over the previous quarter.
- Even though the market (S&P 500) has generated returns of 25.41% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -74.60% returns
How much should you hold?
- Overall Portfolio exposure to Chromadex Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Chromadex Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Fallen by -0.08% (YoY
Highest at USD 131.34 MM
Highest at USD 6.74 MM
Highest at USD 6.32 MM
Highest at USD 0.07
Lowest at USD 4.36 MM
Highest at -77.7 %
Lowest at 2.65 times
Lowest at USD 1.87 MM
Lowest at 5.93 %
Here's what is working for Chromadex Corp.
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Raw Material Cost as a percentage of Sales
Here's what is not working for Chromadex Corp.
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Debt-Equity Ratio
Inventory Turnover Ratio






